Idexx Laboratories Stock Buy Hold or Sell Recommendation
| IDXX Stock | USD 444.53 15.23 3.31% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding IDEXX Laboratories is 'Strong Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell IDEXX Laboratories given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for IDEXX Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out IDEXX Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide. In addition, we conduct extensive research on individual companies such as IDEXX and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
IDEXX |
Execute IDEXX Laboratories Buy or Sell Advice
The IDEXX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on IDEXX Laboratories. Macroaxis does not own or have any residual interests in IDEXX Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute IDEXX Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
IDEXX Laboratories Trading Alerts and Improvement Suggestions
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| IDEXX Laboratories currently holds 1.07 B in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about IDEXX Laboratories' use of debt, we should always consider it together with its cash and equity. | |
| Over 92.0% of IDEXX Laboratories shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: IDEXX Laboratories Fell Due to Weakening of Clinical Visits by Patients |
IDEXX Laboratories Returns Distribution Density
The distribution of IDEXX Laboratories' historical returns is an attempt to chart the uncertainty of IDEXX Laboratories' future price movements. The chart of the probability distribution of IDEXX Laboratories daily returns describes the distribution of returns around its average expected value. We use IDEXX Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of IDEXX Laboratories returns is essential to provide solid investment advice for IDEXX Laboratories.
| Mean Return | 0.06 | Value At Risk | -2.63 | Potential Upside | 2.72 | Standard Deviation | 2.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of IDEXX Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
IDEXX Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as IDEXX Laboratories, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading IDEXX Laboratories back and forth among themselves.
| Shares | Blair William & Co | 2024-09-30 | 1.2 M | Brown Advisory Holdings Inc | 2024-09-30 | 1.1 M | Amvescap Plc. | 2024-09-30 | 1.1 M | Fundsmith Investment Services Ltd. | 2024-09-30 | 865 K | Legal & General Group Plc | 2024-09-30 | 774.7 K | Northern Trust Corp | 2024-09-30 | 769.5 K | Goldman Sachs Group Inc | 2024-09-30 | 768.6 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 751.9 K | Principal Financial Group Inc | 2024-12-31 | 711.2 K | Vanguard Group Inc | 2024-09-30 | 9.7 M | Blackrock Inc | 2024-09-30 | 9.4 M |
IDEXX Laboratories Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (18.9M) | (52.9M) | (121.7M) | (28.7M) | (25.8M) | (24.5M) | |
| Change In Cash | 293.6M | (239.5M) | (31.9M) | 341.4M | (165.7M) | (157.4M) | |
| Free Cash Flow | 540.4M | 636.0M | 394.1M | 772.9M | 808.1M | 848.5M | |
| Depreciation | 96.0M | 104.6M | 111.9M | 114.9M | 132.1M | 138.8M | |
| Other Non Cash Items | 8.8M | 9.3M | 10.8M | 7.6M | 41.1M | 43.2M | |
| Capital Expenditures | 107.6M | 119.5M | 148.8M | 133.6M | 120.9M | 65.6M | |
| Net Income | 582.1M | 744.8M | 679.1M | 845.0M | 887.9M | 932.3M | |
| End Period Cash Flow | 383.9M | 144.5M | 112.5M | 453.9M | 288.3M | 151.8M | |
| Investments | (109.4M) | (293.0M) | (195.4M) | (144.0M) | (129.6M) | (136.1M) | |
| Change Receivables | (22.5M) | (60.7M) | (33.1M) | (41.4M) | (37.3M) | (39.1M) | |
| Net Borrowings | (10.4M) | (94.7M) | 23.5M | 430.1M | 387.1M | 406.4M | |
| Change To Netincome | 48.3M | 1.7M | 148.2M | 25.5M | 29.4M | 28.4M |
IDEXX Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IDEXX Laboratories or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IDEXX Laboratories' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IDEXX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 2.07 | |
Ir | Information ratio | 0.02 |
IDEXX Laboratories Volatility Alert
IDEXX Laboratories has relatively low volatility with skewness of 2.37 and kurtosis of 12.79. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IDEXX Laboratories' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IDEXX Laboratories' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.IDEXX Laboratories Fundamentals Vs Peers
Comparing IDEXX Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IDEXX Laboratories' direct or indirect competition across all of the common fundamentals between IDEXX Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as IDEXX Laboratories or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of IDEXX Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IDEXX Laboratories to competition |
| Fundamentals | IDEXX Laboratories | Peer Average |
| Return On Equity | 0.58 | -0.31 |
| Return On Asset | 0.22 | -0.14 |
| Profit Margin | 0.23 % | (1.27) % |
| Operating Margin | 0.27 % | (5.51) % |
| Current Valuation | 36.98 B | 16.62 B |
| Shares Outstanding | 81.88 M | 571.82 M |
| Shares Owned By Insiders | 1.17 % | 10.09 % |
| Shares Owned By Institutions | 92.24 % | 39.21 % |
| Number Of Shares Shorted | 1.96 M | 4.71 M |
| Price To Earning | 61.31 X | 28.72 X |
| Price To Book | 22.82 X | 9.51 X |
| Price To Sales | 9.34 X | 11.42 X |
| Revenue | 3.9 B | 9.43 B |
| Gross Profit | 2.38 B | 27.38 B |
| EBITDA | 1.13 B | 3.9 B |
| Net Income | 887.87 M | 570.98 M |
| Cash And Equivalents | 114.36 M | 2.7 B |
| Cash Per Share | 1.37 X | 5.01 X |
| Total Debt | 1.07 B | 5.32 B |
| Debt To Equity | 3.27 % | 48.70 % |
| Current Ratio | 0.89 X | 2.16 X |
| Book Value Per Share | 19.49 X | 1.93 K |
| Cash Flow From Operations | 929 M | 971.22 M |
| Short Ratio | 2.87 X | 4.00 X |
| Earnings Per Share | 10.67 X | 3.12 X |
| Price To Earnings To Growth | 4.44 X | 4.89 X |
| Target Price | 501.62 | |
| Number Of Employees | 11 K | 18.84 K |
| Beta | 1.37 | -0.15 |
| Market Capitalization | 36.4 B | 19.03 B |
| Total Asset | 3.26 B | 29.47 B |
| Retained Earnings | 4.44 B | 9.33 B |
| Working Capital | 543.71 M | 1.48 B |
Note: Disposition of 500 shares by Szostak M Anne of IDEXX Laboratories at 469.3723 subject to Rule 16b-3 [view details]
IDEXX Laboratories Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as IDEXX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0415 | |||
| Daily Balance Of Power | (0.79) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 454.02 | |||
| Day Typical Price | 450.85 | |||
| Market Facilitation Index | 19.23 | |||
| Price Action Indicator | (17.10) | |||
| Period Momentum Indicator | (15.23) | |||
| Relative Strength Index | 62.25 |
About IDEXX Laboratories Buy or Sell Advice
When is the right time to buy or sell IDEXX Laboratories? Buying financial instruments such as IDEXX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having IDEXX Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Entertainment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.